Asthma and other respiratory conditions are the third biggest cause of death in the UK and cost the NHS more than £3b in 2022. A Cambridge-based Health Tech company has developed a new technology that […]
The NHS is facing unprecedented pressures this winter, and it is anticipated that patients with respiratory disease may occupy up to half of all hospital beds. It is therefore vital that the management of patients […]
Analysis of UK inhaler medicine use and carbon footprint presented at the British Thoracic Society Winter Meeting New analysis of respiratory inhaler medicine use in the UK shows that 83% of all short-acting beta-2-agonist (SABA) […]
It’s estimated that between 5-10% of asthma sufferers worldwide suffer from severe asthma. Unlike ‘ordinary’ asthma, severe asthma is difficult to treat and to control, and often results in repeated hospitalisations for those who struggle […]
Copyright © 2023 | MH Magazine WordPress Theme by MH Themes
